GHO appoints Miller, Hamilton-Fairley as operating partners
Global Healthcare Opportunities (GHO) has appointed David W Miller and Geoffrey Hamilton-Fairley as operating partners.
Both will support deal origination as well as GHO's portfolio companies.
Miller was formerly senior vice-president of global market access at Biogen with responsibility for the global pricing, reimbursement and access of Biogen's product portfolio, before founding his own advisory practice whose clients have included biotechnology firms of all sizes.
Hamilton-Fairley's experience includes developing and guiding Oncimmune, a company focused on early cancer detection, from a Nottingham University startup through to IPO in May 2016.
The firm is currently investing from GHO Capital II, which closed on €975m in November 2019.
More on People
CapMan Managing Partner Johan Pålsson to depart
Pålsson resigns from management effective immediately; to stay as buyout partner until February 2024
Capvis grapples with EUR 1bn fundraise amid team exodus
Five partners for the Swiss-based GP leave firm in last two years; sponsor started sixth buyout fundraise in early 2023
Golding adds insurance expertise with hire for institutional clients team
Tim Ickenroth joins as director with prior experience at BNP Paribas and UniCredit
Travers Smith bolsters funds practice with hire from Proskauer
Tosin Adeyeri joins with particular experience in secondary portfolio transactions
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater